Grupo Biotoscana announces license agreement for two innovative anti-infective agents

Grupo Biotoscana announced today that it has entered into a supply, distribution and license agreement with Basilea Pharmaceutica International Ltd. for Basilea‘s anti fungal CRESEMBA® (isavuconazole) and Basilea‘s antibiotic Zevtera® (ceftobiprole) in 19 countries in Latin America including Brazil, Mexico, Argentina and Colombia.
Press Release: ENG | ESP | POR